Abstract 1548: Ultraviolet B-induced platelet-activating factor receptor agonists mediate augmentation of melanoma tumor growth via regulatory T cells: Implication of systemic immunosuppression

Author(s):  
Ravi P. Sahu ◽  
Raymond L. Konger ◽  
Christopher E. Touloukian ◽  
Jeffrey B. Travers
2016 ◽  
Vol 136 (5) ◽  
pp. S6
Author(s):  
S. Henning ◽  
F. Navarro ◽  
P. Farhangi Oskuei ◽  
K. Tobin ◽  
M. Fernandez ◽  
...  

2010 ◽  
Vol 86 (4) ◽  
pp. 949-954 ◽  
Author(s):  
Jared B. Travers ◽  
Damien Berry ◽  
Yongxue Yao ◽  
Qiaofang Yi ◽  
Raymond L. Konger ◽  
...  

Author(s):  
Shasha Liu ◽  
Chaoqi Zhang ◽  
Boqiao Wang ◽  
Huanyu Zhang ◽  
Guohui Qin ◽  
...  

AbstractGlioma stem cells (GSCs) contribute to the malignant growth of glioma, but little is known about the interaction between GSCs and tumor microenvironment. Here, we found that intense infiltration of regulatory T cells (Tregs) facilitated the qualities of GSCs through TGF-β secretion that helped coordinately tumor growth. Mechanistic investigations indicated that TGF-β acted on cancer cells to induce the core cancer stem cell-related genes CD133, SOX2, NESTIN, MUSASHI1 and ALDH1A expression and spheres formation via NF-κB–IL6–STAT3 signaling pathway, resulting in the increased cancer stemness and tumorigenic potential. Furthermore, Tregs promoted glioma tumor growth, and this effect could be abrogated with blockade of IL6 receptor by tocilizumab which also demonstrated certain level of therapeutic efficacy in xenograft model. Additionally, expression levels of CD133, IL6 and TGF-β were found to serve as prognosis markers of glioma patients. Collectively, our findings reveal a new immune-associated mechanism underlying Tregs-induced GSCs. Moreover, efforts to target this network may be an effective strategy for treating glioma.


2014 ◽  
Vol 7 ◽  
pp. CGM.S14501 ◽  
Author(s):  
Patrick C. Hackler ◽  
Sarah Reuss ◽  
Raymond L. Konger ◽  
Jeffrey B. Travers ◽  
Ravi P. Sahu

Pro-oxidative stressors including cigarette smoke (CS) generate novel lipids with platelet-activated factor-receptor (PAF-R) agonistic activity mediate systemic immunosuppression, one of the most recognized events in promoting carcinogenesis. Our previous studies have established that these oxidized-PAF-R-agonists augment murine B16F10 melanoma tumor growth in a PAF-R-dependent manner because of its effects on host immunity. As CS generates PAF-R agonists, the current studies sought to determine the impact of PAF-R agonists on lung cancer growth and metastasis. Using the murine Lewis Lung Carcinoma (LLC1) model, we demonstrate that treatment of C57BL/6 mice with a PAF-R agonist augments tumor growth and lung metastasis in a PAF-R-dependent manner as these findings were not seen in PAF-R-deficient mice. Importantly, this effect was because of host rather than tumor cells PAF-R dependent as LLC1 cells do not express functional PAF-R. These findings indicate that experimental lung cancer progression can be modulated by the PAF system.


PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0152823 ◽  
Author(s):  
Akari Hashimoto ◽  
Tsutomu Sato ◽  
Satoshi Iyama ◽  
Masahiro Yoshida ◽  
Soushi Ibata ◽  
...  

2014 ◽  
Vol 193 (11) ◽  
pp. 5488-5497 ◽  
Author(s):  
Sayuri Yamazaki ◽  
Akiko Nishioka ◽  
Saori Kasuya ◽  
Naganari Ohkura ◽  
Hiroaki Hemmi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document